Cargando…

Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer

PURPOSE: To evaluate the dosimetry of a six-channel high-dose-rate (HDR) applicator for treatment of esophageal cancer with respect to lateral directionality and heterogeneous media. MATERIAL AND METHODS: A computed tomography (CT)- and magnetic resonance imaging (MRI)-compatible esophageal applicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Anzi, Gao, Shengqiang, Greskovich, John, Wilkinson, Douglas Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170515/
https://www.ncbi.nlm.nih.gov/pubmed/34122572
http://dx.doi.org/10.5114/jcb.2021.106049
_version_ 1783702261258518528
author Zhao, Anzi
Gao, Shengqiang
Greskovich, John
Wilkinson, Douglas Allan
author_facet Zhao, Anzi
Gao, Shengqiang
Greskovich, John
Wilkinson, Douglas Allan
author_sort Zhao, Anzi
collection PubMed
description PURPOSE: To evaluate the dosimetry of a six-channel high-dose-rate (HDR) applicator for treatment of esophageal cancer with respect to lateral directionality and heterogeneous media. MATERIAL AND METHODS: A computed tomography (CT)- and magnetic resonance imaging (MRI)-compatible esophageal applicator consisting of 2 inflatable portions (anchor and therapeutic balloons) with 6 longitudinal treatment catheters equally spaced circumferentially was constructed. Treatment plans were prepared using Oncentra 4.5 for various catheter loadings and target locations and sizes. Calculated dose distributions were compared to measured distributions obtained using film and a water phantom. Balloon inflations with water and with air were tested. RESULTS: TG-43 dose calculations matched measurements well when inflation balloons were filled with water. When air was used to inflate, model-based dose calculations (TG-186) improved the comparison with measurement. Several cases with simulated ring targets demonstrated better dose conformity to non-uniform targets compared to a single central catheter. Additionally, the use of this applicator compared to a single catheter, gave rise to considerable improvement in sparing non-target tissue. CONCLUSIONS: Lateral dose modulation is achievable with the applicator described in this work. The use of TG-186 dose calculation made a small improvement in heterogeneous media.
format Online
Article
Text
id pubmed-8170515
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-81705152021-06-11 Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer Zhao, Anzi Gao, Shengqiang Greskovich, John Wilkinson, Douglas Allan J Contemp Brachytherapy Original Paper PURPOSE: To evaluate the dosimetry of a six-channel high-dose-rate (HDR) applicator for treatment of esophageal cancer with respect to lateral directionality and heterogeneous media. MATERIAL AND METHODS: A computed tomography (CT)- and magnetic resonance imaging (MRI)-compatible esophageal applicator consisting of 2 inflatable portions (anchor and therapeutic balloons) with 6 longitudinal treatment catheters equally spaced circumferentially was constructed. Treatment plans were prepared using Oncentra 4.5 for various catheter loadings and target locations and sizes. Calculated dose distributions were compared to measured distributions obtained using film and a water phantom. Balloon inflations with water and with air were tested. RESULTS: TG-43 dose calculations matched measurements well when inflation balloons were filled with water. When air was used to inflate, model-based dose calculations (TG-186) improved the comparison with measurement. Several cases with simulated ring targets demonstrated better dose conformity to non-uniform targets compared to a single central catheter. Additionally, the use of this applicator compared to a single catheter, gave rise to considerable improvement in sparing non-target tissue. CONCLUSIONS: Lateral dose modulation is achievable with the applicator described in this work. The use of TG-186 dose calculation made a small improvement in heterogeneous media. Termedia Publishing House 2021-05-12 2021-06 /pmc/articles/PMC8170515/ /pubmed/34122572 http://dx.doi.org/10.5114/jcb.2021.106049 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Original Paper
Zhao, Anzi
Gao, Shengqiang
Greskovich, John
Wilkinson, Douglas Allan
Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
title Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
title_full Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
title_fullStr Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
title_full_unstemmed Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
title_short Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
title_sort pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170515/
https://www.ncbi.nlm.nih.gov/pubmed/34122572
http://dx.doi.org/10.5114/jcb.2021.106049
work_keys_str_mv AT zhaoanzi preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer
AT gaoshengqiang preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer
AT greskovichjohn preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer
AT wilkinsondouglasallan preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer